Page No. |
||||||
Index to Audited Consolidated Financial Statements of Stem, Inc. as of and for the Years ended December 31, 2020 and December 31, 2019 |
||||||
F-2 |
||||||
F-3 |
||||||
F-4 |
||||||
F-5 |
||||||
F-6 |
||||||
F-7 |
||||||
F-8 |
December 31, |
||||||||
2020 |
2019 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable, net |
||||||||
Inventory, net |
||||||||
Other current assets (includes $ |
||||||||
Total current assets |
||||||||
Energy storage systems, net |
||||||||
Contract origination costs, net |
||||||||
Goodwill |
||||||||
Intangible assets, net |
||||||||
Other noncurrent assets |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued liabilities |
||||||||
Accrued payroll |
||||||||
Notes payable, current portion |
||||||||
Convertible promissory notes (includes $ |
||||||||
Financing obligation, current portion |
||||||||
Deferred revenue, current |
||||||||
Other current liabilities (includes $ |
||||||||
Total current liabilities |
||||||||
Deferred revenue, noncurrent |
||||||||
Asset retirement obligation |
||||||||
Notes payable, noncurrent |
||||||||
Financing obligation, noncurrent |
||||||||
Warrant liabilities |
||||||||
Lease liability, noncurrent |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 18) |
||||||||
Stockholders’ Deficit: |
||||||||
Preferred stock, $ |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive (loss) income |
( |
) | ||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total stockholders’ deficit |
( |
) | ( |
) | ||||
Total liabilities, convertible preferred stock and stockholders’ deficit |
$ | $ | ||||||
Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Service revenue |
$ | $ | ||||||
Hardware revenue |
||||||||
Total revenue |
||||||||
Cost of service revenue |
||||||||
Cost of hardware revenue |
||||||||
Total cost of revenue |
||||||||
Gross margin |
( |
) | ( |
) | ||||
Operating expenses: |
||||||||
Sales and marketing |
||||||||
Research and development |
||||||||
General and administrative |
||||||||
Total operating expenses |
||||||||
Loss from operations |
( |
) | ( |
) | ||||
Other income (expense), net: |
||||||||
Interest expense |
( |
) | ( |
) | ||||
Change in fair value of warrants and embedded derivative |
( |
) | ||||||
Other expenses, net |
( |
) | ( |
) | ||||
Total other income (expense) |
( |
) | ( |
) | ||||
Loss before income taxes |
( |
) | ( |
) | ||||
Income tax expense |
( |
) | ( |
) | ||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Net loss per share attributable to common shareholders, basic and diluted |
$ | ( |
) | $ | ( |
) | ||
Weighted-average shares used in computing net loss per share, basic and diluted |
||||||||
Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Other comprehensive (loss) income: |
||||||||
Foreign currency translation adjustment |
( |
) | ||||||
Total comprehensive loss |
$ | ( |
) | $ | ( |
) | ||
Convertible Preferred Stock |
Series 1 Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||
Balance at January 1, 2019 |
$ | $ | $ | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||||||||||||||
Retroactive application of recapitalization (Note 1) |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Adjusted balance, beginning of period |
( |
) | ||||||||||||||||||||||||||||||||||||||
Effect of Exchange Transaction (Note 11) |
— | — | — | — | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Issuance of warrants to purchase common stock |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Issuance of shares upon conversion of promissory note |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Settlement of litigation (Note 18) |
— | — | — | — | ( |
) | — | — | — | — | — | |||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options and warrants |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance as of December 31, 2019 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
Effect of exchange transaction (Note 11) |
— | — | — | — | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Cancellation of exchange transaction by shareholder (Note 11) |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Recognition of beneficial conversion feature related to convertible notes (Note 11) |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Issuance of warrants to purchase common stock |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Issuance of shares upon exercise of stock options and warrants |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance as of December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
OPERATING ACTIVITIES |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization expense |
||||||||
Non-cash interest expense, including interest expense associated with debt issuance costs |
||||||||
Stock-based compensation |
||||||||
Change in fair value of warrant liability and embedded derivative |
( |
) | ||||||
Noncash lease expense |
||||||||
Accretion expense |
||||||||
Impairment of energy storage systems |
||||||||
Earnings from equity method investments |
( |
) | ( |
) | ||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
( |
) | ( |
) | ||||
Inventory |
( |
) | ( |
) | ||||
Other assets |
( |
) | ( |
) | ||||
Contract origination costs |
( |
) | ( |
) | ||||
Accounts payable and accrued expenses |
||||||||
Deferred revenue |
||||||||
Lease liabilities |
( |
) | ( |
) | ||||
Other liabilities |
( |
) | ||||||
Net cash used in operating activities |
( |
) | ( |
) | ||||
INVESTING ACTIVITIES |
||||||||
Purchase of energy storage systems |
( |
) | ( |
) | ||||
Capital expenditures on internally-developed software |
( |
) | ( |
) | ||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
FINANCING ACTIVITIES |
||||||||
Proceeds from exercise of stock options and warrants |
||||||||
Proceeds from financing obligations |
||||||||
Repayment of financing obligations |
( |
) | ( |
) | ||||
Proceeds from issuance of convertible notes, net of issuance costs of $ |
||||||||
Proceeds from issuance of notes payable, net of issuance costs of $ |
||||||||
Repayment of notes payable |
( |
) | ( |
) | ||||
Net cash provided by financing activities |
||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | ( |
) | ||||
Net decrease in cash and cash equivalents |
( |
) | ( |
) | ||||
Cash and cash equivalents, beginning of year |
||||||||
Cash and cash equivalents, end of year |
$ | $ | ||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION |
||||||||
Cash paid for income taxes |
$ | $ | ||||||
Cash paid for interest |
$ | $ | ||||||
NON-CASH INVESTING AND FINANCING ACTIVITIES |
||||||||
Change in asset retirement costs and asset retirement obligation |
$ | $ | ( |
) | ||||
Issuance of common stock warrants |
$ | $ | ||||||
Conversion of convertible promissory notes and accrued interest into Series D preferred stock |
$ | $ | ||||||
Conversion of accrued interest into outstanding note payable |
$ | $ | ||||||
Purchase of energy storage systems in accounts payable |
$ | $ |
Accounts Receivable |
Revenue |
|||||||||||||||
December 31, |
Years Ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Customers: |
||||||||||||||||
Customer A |
* | % | % | * | ||||||||||||
Customer B |
% | * | * | * | ||||||||||||
Customer C |
% | * | * | * | ||||||||||||
Customer D |
% | * | % | * |
* | Total less than 10% for the respective period |
December 31, |
||||||||
2020 |
2019 |
|||||||
Partnership hardware revenue |
$ | $ | ||||||
Partnership service revenue |
||||||||
Host customer service revenue |
||||||||
|
|
|
|
|||||
Total revenue |
$ | $ | ||||||
|
|
|
|
Total remaining performance obligations |
Percent expected to be recognized as revenue |
|||||||||||||||
Less than one year |
Two to five years |
Greater than five year |
||||||||||||||
(in thousands, except percentages) |
||||||||||||||||
Service revenue |
$ |
% | % | % | ||||||||||||
Hardware revenue |
% | — | — | |||||||||||||
|
|
|||||||||||||||
Total revenue |
$ |
December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance at January 1, |
$ | $ | ||||||
Upfront payments received from customers |
||||||||
Upfront or annual incentive payments received |
||||||||
Revenue recognized related to amounts that were included in beginning balance of deferred revenue |
( |
) | ( |
) | ||||
Revenue recognized |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Ending balance at December 31, |
$ | $ | ||||||
|
|
|
|
December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Cash equivalents: |
$ | $ | — | $ | — | $ | ||||||||||
Money market fund |
||||||||||||||||
Liabilities |
||||||||||||||||
Convertible preferred stock warrant liabilities |
$ | — | $ | — | $ | $ | ||||||||||
Embedded derivative liabilities |
$ | — | $ | — | $ | — | $ | — | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ | — | $ | — | $ | $ | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
December 31, 2019 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Cash equivalents: |
$ | $ | — | $ | — | $ | ||||||||||
Money market fund |
||||||||||||||||
Liabilities |
||||||||||||||||
Convertible preferred stock warrant liabilities |
$ | — | $ | — | $ | $ | ||||||||||
Embedded derivative liabilities |
$ | — | $ | — | $ | $ | ||||||||||
Total liabilities |
$ | — | $ | — | $ | $ |
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Expected term (in years) |
||||||||
Dividend yield |
— | % | — | % | ||||
Discount for lack of marketability |
% | % |
December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance at January 1, |
$ | $ | ||||||
Issuance of warrants |
||||||||
Change in fair value of warrants |
||||||||
Exercised warrants |
( |
) | — | |||||
|
|
|
|
|||||
Ending balance at December 31, |
$ | $ | ||||||
|
|
|
|
December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance at January 1, |
$ | $ | — | |||||
Issuance of derivative |
||||||||
Change in fair value |
( |
) | ( |
) | ||||
Ending balance at December 31, |
$ | — | $ | |||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Goodwill |
$ | $ | ||||||
Effect of foreign currency translation |
||||||||
Total goodwill |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Developed technology |
$ | $ | ||||||
Internally developed software |
||||||||
Intangible assets |
||||||||
Less: Accumulated amortization |
( |
) | ( |
) | ||||
Add: Currency translation adjustment |
||||||||
Total intangible assets, net |
$ | $ | ||||||
Operating Leases |
||||
2021 |
$ | |||
2022 |
||||
Total lease payments |
||||
Less: imputed interest |
( |
) | ||
Total operating lease liability future lease payments |
$ | |||
December 31, |
||||||||
2020 |
2019 |
|||||||
Current portion of operating lease liabilities included within other current liabilities |
$ | $ | ||||||
Non-current portion of operating lease liabilities |
||||||||
Total |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Weighted average remaining operating lease term (in years) |
||||||||
Weighted average discount rate |
% | % |
December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance at January 1, |
$ | $ | ||||||
Asset retirement obligation |
||||||||
Settlement of asset retirement obligation |
( |
) | ||||||
Retirement cost revaluation |
( |
) | ( |
) | ||||
Accretion expense |
||||||||
Ending balance at December 31, |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Energy storage systems placed into service |
$ | $ | ||||||
Less accumulated depreciation |
( |
) | ( |
) | ||||
Energy storage systems not yet placed into service |
||||||||
Total energy storage systems, net |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Work in process inventory |
$ | $ | ||||||
Batteries |
||||||||
Total inventory |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Deferred costs with suppliers |
$ | $ | ||||||
Prepaid expenses |
||||||||
Utility program deposits |
||||||||
Due from related parties |
||||||||
Other |
||||||||
Total other current assets |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Receivable from SPEs (Note 15) |
$ | $ | ||||||
Deferred SPAC costs |
||||||||
Self-generation incentive program deposits |
||||||||
Investment in VIEs |
||||||||
Revolver debt issuance costs |
||||||||
Right-of-use |
||||||||
Property and equipment, net |
||||||||
Other |
||||||||
Total other noncurrent assets |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Accrued payables |
$ | $ | ||||||
Accrued interest–notes payable |
||||||||
Other accrued liabilities |
||||||||
Total accrued liabilities |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
System advances |
$ | $ | ||||||
Lease liabilities–current portion |
||||||||
Due to related parties |
||||||||
Other |
||||||||
Total other current liabilities |
$ | $ | ||||||
December 31, 2020 |
||||
Outstanding principal |
$ | |||
Unamortized discount |
( |
) | ||
Carrying value of debt |
$ | |||
Payment Schedule |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
Total |
$ | |||
|
|
December 31, 2020 | ||||||||||||
Issuance Date |
Exercise Price |
Number of Shares |
Term (years) | |||||||||
Series A’ |
2012 | $ | ||||||||||
Series D |
2017 | |||||||||||
Series D’ |
2019 and 2020 | ** | ||||||||||
|
|
|||||||||||
Total |
||||||||||||
|
|
December 31, 2019 | ||||||||||||
Issuance Date |
Exercise Price |
Number of Shares |
Term (years) | |||||||||
Series A’ |
2012 | $ | ||||||||||
Series D |
2017 | |||||||||||
Series D’ |
2019 | ** | ||||||||||
|
|
|||||||||||
Total |
||||||||||||
|
|
** | In connection with various issuances of Convertible Notes that occurred during 2019 and 2020, warrants to purchase either next financing stock or Series D’ preferred stock were issued. At December 31, 2020 and December 31, 2019, the number of warrants issued was subject to adjustment pending the occurrence of the next round of financing; however, the number of shares and exercise price of these warrants and related valuation of these warrants has been performed assuming that the warrants will be on Series D’ preferred stock. |
December 31, 2020 |
||||||||||||||||
Authorized Shares |
Outstanding Shares |
Net Carrying Value |
Liquidation Preference |
|||||||||||||
(in thousands) |
||||||||||||||||
Series D’ |
$ | $ | ||||||||||||||
Series D |
||||||||||||||||
Series C |
||||||||||||||||
Series B |
||||||||||||||||
Series A’ |
||||||||||||||||
Series A |
||||||||||||||||
Series 1 |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | ||||||||||||||
|
|
|
|
|
|
|
|
December 31, 2019 |
||||||||||||||||
Authorized Shares |
Outstanding Shares |
Net Carrying Value |
Liquidation Preference |
|||||||||||||
(in thousands) |
||||||||||||||||
Series D’ |
$ | $ | ||||||||||||||
Series D |
||||||||||||||||
Series C |
||||||||||||||||
Series B |
||||||||||||||||
Series A’ |
||||||||||||||||
Series A |
||||||||||||||||
Series 1 |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | $ | ||||||||||||||
|
|
|
|
|
|
|
|
December 31, |
||||||||
2020 |
2019 |
|||||||
Shares reserved for warrants |
||||||||
Options issued and outstanding |
||||||||
Shares available for future option grants |
||||||||
Total |
||||||||
Number of Options Outstanding |
Weighted- Average Exercise Price Per Share |
Weighted- Average Remaining Contractual Life (years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Balances as of December 31, 2019 |
$ | $ | ||||||||||||||
Retroactive application of recapitalization |
( |
) | — | — | ||||||||||||
Adjusted balance as of December 31, 2019 |
||||||||||||||||
Options granted |
||||||||||||||||
Options exercised |
( |
) | ||||||||||||||
Options forfeited |
( |
) | ||||||||||||||
Options expired |
( |
) | ||||||||||||||
Balances as of December 31, 2020 |
$ | $ | ||||||||||||||
Options vested and exercisable – December 31, 2020 |
$ | $ | ||||||||||||||
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Expected term (in years) |
||||||||
Dividend yield |
— | % | — | % |
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Sales and marketing |
$ | $ | ||||||
Research and development |
||||||||
General and administrative |
||||||||
|
|
|
|
|||||
Total stock-based compensation expense |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Energy storage systems, net |
$ | $ | ||||||
Deferred revenue, current |
$ | $ | ||||||
Deferred revenue, noncurrent |
$ | $ | ||||||
Other liabilities |
$ | $ |
SPV II |
SPV III |
SPV IV | ||||
Date formed | January 23, 2015 | June 7, 2016 | June 30, 2017 | |||
Initial ownership % | ||||||
Stem’s interest | ||||||
Initial distributions: | ||||||
Class A | ||||||
Class B |
December 31, |
||||||||
2020 |
2019 |
|||||||
Investment in SPV II |
$ | — | $ | — | ||||
Investment in SPV III |
||||||||
Investment in SPV IV |
||||||||
Total equity method investments |
$ | $ | ||||||
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Financing obligation, current portion |
$ | $ | ||||||
Financing obligation, noncurrent |
$ | $ |
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Energy storage systems, net |
$ | $ | ||||||
Deferred revenue, current |
$ | $ | ||||||
Deferred revenue, noncurrent |
$ | $ | ||||||
Other liabilities |
$ | $ |
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Numerator: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Less: Deemed dividend to preferred stockholders (see Note 11) |
( |
) | ( |
) | ||||
Net loss attributable to common stockholders |
( |
) | ( |
) | ||||
Denominator: |
||||||||
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted |
||||||||
Net loss per share attributable to common stockholders, basic and diluted Net loss per share attributable to common stockholders, basic and diluted |
$ | ( |
) | $ | ( |
) | ||
December 31, |
||||||||
2020 |
2019 |
|||||||
Convertible promissory notes |
||||||||
Outstanding stock options |
||||||||
Outstanding common stock warrants |
||||||||
Total |
||||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Domestic |
$ | ( |
) | $ | ( |
) | ||
Foreign |
— | — | ||||||
|
|
|
|
|||||
Loss before income taxes |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
December 31, |
||||||||
2020 |
2019 |
|||||||
Current: |
||||||||
Federal |
$ | $ | ||||||
State |
||||||||
|
|
|
|
|||||
Total current |
||||||||
|
|
|
|
|||||
Deferred: |
||||||||
Federal |
||||||||
State |
||||||||
|
|
|
|
|||||
Total deferred |
||||||||
|
|
|
|
|||||
Total provision for income taxes |
$ | $ | ||||||
|
|
|
|
December 31, |
||||||||
2020 |
2019 |
|||||||
Statutory rate |
% | % | ||||||
State tax |
% | % | ||||||
Foreign income and withholding taxes |
% | % | ||||||
Stock-based compensation |
( |
)% | ( |
)% | ||||
Change in fair value of warrants |
( |
)% | % | |||||
Other |
— | ( |
)% | |||||
Non-deductible interest expense |
( |
)% | ( |
)% | ||||
Valuation allowance |
( |
)% | ( |
)% | ||||
|
|
|
|
|||||
Total |
% | % | ||||||
|
|
|
|
December 31, |
||||||||
2020 |
2019 |
|||||||
Deferred tax assets: |
||||||||
Net operating losses |
$ | $ | ||||||
Tax credits |
||||||||
Depreciable assets |
||||||||
Intangible assets |
— | |||||||
Accruals and allowances |
||||||||
Stock-based compensation |
||||||||
Deferred revenue |
||||||||
Other |
||||||||
|
|
|
|
|||||
Total gross deferred tax assets |
||||||||
Less: Valuation allowance |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net deferred tax assets |
||||||||
Deferred tax liabilities: |
||||||||
Amortization of asset retirement obligation |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total gross deferred tax liabilities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net deferred taxes |
$ | — | $ | — | ||||
|
|
|
|